Ketorolac Effects on Post-operative Pain and Lumbar Fusion
NCT ID: NCT06513208
Last Updated: 2025-12-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE4
140 participants
INTERVENTIONAL
2026-01-31
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ketorolac arm
Ketorolac Tromethamine
IV Ketorolac 15mg every 6 hours, x 4 doses
Placebo Arm
Placebo
IV saline as placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ketorolac Tromethamine
IV Ketorolac 15mg every 6 hours, x 4 doses
Placebo
IV saline as placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Elective posterior lumbar instrumented fusion
* One or two level fusion
* Consent to participate in study and willing to adhere to study follow up
* English proficiency
Exclusion Criteria
* History of renal failure, dialysis, or creatinine over 1.50 mg/dl
* Active or recent smoker (active within past 6 months)
* Revision surgery
* Auto/worker compensation
* Active cancer or history of chemotherapy in past 6 months
* Active narcotic use within 3 months of surgery date
* Infection at operative levels
* Any allergies to NSAIDs or Opioids
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical Metrics Diagnostics, Inc
INDUSTRY
University of Maryland St. Joseph Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Maryland St. Joseph Medical Center
Towson, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Sam Rudow
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HP-00109853
Identifier Type: -
Identifier Source: org_study_id